A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE

A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE

Successful disease-modifying drug development for Alzheimer’s disease has hit a roadblock with the recent failures of amyloid-based therapies, highlighting the translational disconnect between preclinical animal models and clinical outcome. Although disease-modifying therapies are the Holy Grail to...

Full description

Bibliographic Details
Main Authors:	Hugo eGeerts, Athan eSpiros, Patrick eRoberts, Robert eCarr
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-04-01
Series:	Frontiers in Pharmacology
Subjects:	Alzheimer Disease Apathy Cognition Computer Simulation Drug Discovery
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00047/full

Similar Items

A HUMANIZED CLINICALLY CALIBRATED QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL FOR HYPOKINETIC MOTOR SYMPTOMS IN PARKINSON’S DISEASE
by: Hugo eGeerts, et al.
Published: (2016-02-01)

Negative Symptoms in Schizophrenia: Exploring Glutamatergic Modulation Using a Computer-Based Quantitative Systems Pharmacology Approach
by: Hugo eGeerts, et al.
Published: (2014-10-01)

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in Cognitive Impairment in Schizophrenia. A virtual human patient trial using Quantitative Systems Pharmacology
by: Hugo eGeerts, et al.
Published: (2015-09-01)

Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model
by: Hugo Geerts, et al.
Published: (2018-02-01)

A biophysically realistic computer model of Alzheimer pathology to guide the development of symptomatic drugs
by: Roberts Patrick D, et al.
Published: (2012-07-01)

Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: A systematic review
by: Raiana Lídice Mór Fukushima, et al.

Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy
by: R. Ceponiene, et al.
Published: (2016-12-01)

Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation
by: Dana Mohammad, et al.
Published: (2019-06-01)

Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions
by: Alessio Simonetti, et al.
Published: (2020-09-01)

Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study
by: Athan Spiros, et al.
Published: (2021-09-01)

Anosognosia in Early- and Late-Onset Dementia and Its Association With Neuropsychiatric Symptoms
by: Manuela Tondelli, et al.
Published: (2021-05-01)

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
by: Athan Spiros, et al.
Published: (2010-09-01)

Behavioral and psychological symptoms in dementia is not a unitary concept: A critical review with emphasis on Alzheimer's disease
by: Jerson Laks, et al.

IS DOPAMINE INVOLVED IN ALZHEIMER’S DISEASE?
by: Alessandro eMartorana, et al.
Published: (2014-09-01)

Dysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly in nursing homes
by: Agnes Lindbo, et al.
Published: (2017-09-01)

Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer’s Disease: Insights From Preclinical Models, Clinical Data, and Future Directions
by: Amalie Clement, et al.
Published: (2020-03-01)

Expanding the Model of Apathy in Parkinson's Disease: Exploration of Conceptual Domains and Identification of Neuropsychological Correlates
by: Myerson, Connie
Published: (2011)

Apathy in Alzheimer's disease: Contribution to a clinical view on progression of dementia
by: Florindo Stella, et al.

Distinct neuropsychological correlates of cognitive, behavioural and affective apathy sub-domains in acquired brain injury.
by: Progress eNjomboro, et al.
Published: (2014-05-01)

‘Kitchen and cooking’, a serious game for Mild Cognitive Impairment and Alzheimer’s Disease: a pilot study
by: Valeria eManera, et al.
Published: (2015-03-01)

Apathy, cognitive function and motor function in Alzheimer's disease
by: Salma S. Soleman Hernandez, et al.

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
by: Kathy Dujardin, et al.
Published: (2020-01-01)

Resignation syndrome: Catatonia? Culture-bound?
by: Karl eSallin, et al.
Published: (2016-01-01)

Responses to social vocalizations in the dorsal cochlear nucleus of mice
by: Patrick eRoberts, et al.
Published: (2015-12-01)

Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
by: Christos G. Theleritis, et al.
Published: (2019-10-01)

New approaches to symptomatic treatments for Alzheimer’s disease
by: Jeffrey Cummings
Published: (2021-01-01)

HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits
by: Kristen A. McLaurin, et al.
Published: (2021-08-01)

Improving well-being in patients with major neurodegenerative disorders: differential efficacy of brief social robot-based intervention for 3 neuropsychiatric profiles
by: Demange M, et al.
Published: (2018-07-01)

Development of the Positive Emotions Program for Schizophrenia (PEPS): an intervention to improve pleasure and motivation in schizophrenia
by: Alexandra eNguyen, et al.
Published: (2016-02-01)

The effects of apathy and depression on cognitive and functional outcomes in Alzheimer's disease
by: Lekhutlile, Tlholego
Published: (2021)

The Association Between Impaired Awareness and Depression, Anxiety, and Apathy in Mild to Moderate Alzheimer's Disease: A Systematic Review
by: Ignacia Azocar, et al.
Published: (2021-02-01)

The translational study of apathy – an ecological approach
by: Flurin eCathomas, et al.
Published: (2015-09-01)

On histamine and appetites
by: Fernando eTorrealba, et al.
Published: (2012-07-01)

Correlations of apathy with clinical symptoms of Alzheimer’s disease and olfactory dysfunctions: a cross-sectional study
by: Shu-yang Yu, et al.
Published: (2020-11-01)

Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response.
by: Hugo Geerts, et al.
Published: (2012-01-01)

Apathy symptoms modulate motivational decision making on the Iowa gambling task
by: Njomboro Progress, et al.
Published: (2012-12-01)

Emotional Comparison Between Semantic Dementia and Alzheimer's Disease
by: Ping Wang, et al.
Published: (2021-05-01)

Apathy in Parkinson`s disease is related to executive function, gender and age but not to depression
by: Antonia eMeyer, et al.
Published: (2015-01-01)

Effects of donepezil on behavioural manifestations of thalamic infarction: a single case observation
by: Rodrigo eRiveros, et al.
Published: (2011-03-01)

Subclinical Cognitive and Neuropsychiatric Correlates and Hippocampal Volume Features of Brain White Matter Hyperintensity in Healthy People
by: Gianfranco Spalletta, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_qjqu6rdqgrfsa153noktgl961b